Search Tag: clinical-stage biotechnology

Executive Health Management

Kineta Appoints Keith Baker as Chief Financial Officer

2022 04 Oct

Kineta, Inc, a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology announced the appointment of Keith Baker as the Company’s new Chief Financial Officer (CFO). “It is a pleasure to welcome Keith to our management team at this pivotal time for Kineta,” said Shawn Iadonato, Ph.D., Chief Executive Officer... Read more

Executive Health Management

Cardiff Oncology Announces Departure of Chief Medical Officer

2022 12 Apr

Cardiff Oncology, Inc., a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers has announced that  Katherine L. Ruffner , M.D., chief medical officer (CMO), will be leaving the Company on  April 22, 2022 , to pursue a new opportunity. Dr. Ruffner will provide Cardiff Oncology with transitional... Read more